AVE
Click for more information
16.7% 0.3¢ avecho biotechnology limited

deal with nestle

  1. robertsharron
    214 Posts.
    clock Created with Sketch.
    28/04/06
    10:52
    Post #: 1526151
    deal with Nestle will lead to POH becoming manufacturer and supplier of high margin phosphorilated Vitamin E to worlds biggest food group. This is potentially enormous.

    Backed up by similar arrangement with Johnson and Johnson for Transdermal has the potential to be huge for this company both by way of milestone payments and now royalties on top of margin business.



    POH Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
NEWS Talking Australia's very competitive property landscape: Realty Talks
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢ 		Change
-0.001(16.7%) 		Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $25 10K

Buyers (Bids)

No. Vol. Price($)
65 91168236 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 62801585 14
View Market Depth
Last trade - 10.43am 23/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.